Indivior (NASDAQ:INDV) Shares Gap Down to $15.34

Indivior PLC (NASDAQ:INDVGet Free Report) shares gapped down before the market opened on Tuesday . The stock had previously closed at $15.34, but opened at $9.24. Indivior shares last traded at $9.96, with a volume of 433,205 shares.

Analysts Set New Price Targets

Separately, Craig Hallum dropped their price target on Indivior from $37.00 to $24.00 and set a “buy” rating on the stock in a research report on Wednesday.

Check Out Our Latest Stock Report on Indivior

Indivior Stock Up 3.1 %

The company has a market capitalization of $1.45 billion, a price-to-earnings ratio of 1,051.00 and a beta of 0.69. The company has a current ratio of 0.92, a quick ratio of 0.74 and a debt-to-equity ratio of 23.50. The firm’s 50 day simple moving average is $16.68 and its 200-day simple moving average is $18.01.

Indivior (NASDAQ:INDVGet Free Report) last announced its quarterly earnings data on Thursday, April 25th. The company reported $0.37 earnings per share for the quarter, missing analysts’ consensus estimates of $0.38 by ($0.01). Indivior had a return on equity of 842.72% and a net margin of 0.44%. The business had revenue of $284.00 million for the quarter, compared to analyst estimates of $300.00 million. On average, sell-side analysts anticipate that Indivior PLC will post 1.93 EPS for the current fiscal year.

Institutional Investors Weigh In On Indivior

Several institutional investors have recently modified their holdings of INDV. Norges Bank purchased a new stake in Indivior during the fourth quarter worth $36,011,000. Lingotto Investment Management LLP boosted its position in shares of Indivior by 115.7% in the 4th quarter. Lingotto Investment Management LLP now owns 590,000 shares of the company’s stock worth $8,913,000 after buying an additional 316,435 shares in the last quarter. Vanguard Group Inc. grew its stake in Indivior by 0.9% in the 4th quarter. Vanguard Group Inc. now owns 5,899,190 shares of the company’s stock valued at $90,081,000 after acquiring an additional 52,836 shares during the last quarter. Royal London Asset Management Ltd. increased its holdings in Indivior by 5.8% during the 4th quarter. Royal London Asset Management Ltd. now owns 447,828 shares of the company’s stock valued at $6,838,000 after acquiring an additional 24,383 shares in the last quarter. Finally, UBS Group AG raised its position in Indivior by 71.9% during the fourth quarter. UBS Group AG now owns 826,130 shares of the company’s stock worth $12,615,000 after acquiring an additional 345,556 shares during the last quarter. Hedge funds and other institutional investors own 60.33% of the company’s stock.

About Indivior

(Get Free Report)

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.

Further Reading

Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with's FREE daily email newsletter.